中国多中心早期胃癌保迷走神经胃切除术淋巴结转移风险评估
本研究基于中国11中心1210例早期胃癌患者资料,评估保迷走神经胃切除术的围手术期安全性与术后生活质量,并探索迷走神经相关淋巴结转移风险因素,构建6分风险评估模型用于指导手术选择。
要点
- 保迷走神经胃切除术可缩短术后住院时间、加快引流管拔除、减少腹泻、反酸和术后胆结石发生。
- 肿瘤大小、分化类型、浸润深度和淋巴管侵犯是迷走神经相关淋巴结转移的独立危险因素。
- 6分风险评估模型在训练、内部验证、外部验证和保迷走神经胃切除术队列中AUC分别为0.796、0.806、0.808、0.829。
核心结论
- 保迷走神经胃切除术可改善早期胃癌患者术后生活质量并确保围手术期安全。
- 迷走神经相关淋巴结转移风险评估模型是指导早期胃癌患者选择最佳手术方式和治疗策略的重要工具。
研究设计与样本
- 多中心回顾性分析,纳入中国11个中心1210例早期胃癌患者的临床病理数据。
- 收集800例有随访信息的患者和48例接受保迷走神经胃切除术的患者用于验证。
- 采用倾向性评分匹配分析保迷走神经胃切除术患者的围手术期安全性和生活质量。
主要发现
- 保迷走神经胃切除术患者术后住院时间更短、引流停止更快,腹泻、反酸和术后胆结石发生率更低。
- 迷走神经相关淋巴结转移的关键独立危险因素包括肿瘤大小、分化类型、浸润深度和淋巴管侵犯。
- 基于上述因素建立的6分风险评估模型在训练队列、内部验证队列、外部验证队列和保迷走神经胃切除术队列中的AUC分别为0.796、0.806、0.808和0.829。
- 该模型在术后生存方面能有效区分高风险和低风险组。
关键数值与推荐
- 6分风险评估模型用于评估早期胃癌患者保迷走神经胃切除术后迷走神经相关淋巴结转移风险。
- 模型在训练队列、内部验证队列、外部验证队列和保迷走神经胃切除术队列的AUC分别为0.796、0.806、0.808、0.829。
临床怎么用
- 对于早期胃癌患者,保迷走神经胃切除术可考虑用于改善术后生活质量和围手术期安全。
- 可利用6分风险评估模型评估迷走神经相关淋巴结转移风险,以指导手术方式和治疗策略的选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vagus nerve-preserving gastrectomy is gaining popularity for early gastric cancer treatment. This study assesses vagus nerve-preserving gastrectomy's perioperative safety and impact on postoperative quality of life, and explores vagus nerve-associated lymph node metastasis to create a risk model for enhanced therapy. METHODS: Clinicopathologic data from 1,210 early gastric cancer patients across 11 Chinese centers were analyzed, and the data of 800 patients with follow-up information and 48 patients who underwent vagus nerve-preserving gastrectomy for validation were collected. Propensity score matching was applied to the analysis of perioperative safety and quality of life in vagus nerve-preserving gastrectomy patients. A 6-point risk assessment model was devised and validated to evaluate the risk of vagus nerve-associated lymph node metastasis after vagus nerve-preserving gastrectomy in early gastric cancer patients. RESULTS: Vagus nerve-preserving gastrectomy patients had shorter postoperative stays, quicker drainage cessation, and fewer incidences of diarrhea, acid reflux, and postoperative gallstones. Additionally, key independent risk factors for vagus nerve-associated lymph node metastasis included tumor size, differentiation type, invasion depth, and lymphatic vessel invasion. Using these factors, a 6-point risk assessment model was established. The values of the area under the receiver operating characteristic curve for the model were 0.796, 0.806, 0.808, and 0.829 in the training cohort, internal validation cohort, external validation cohort, and vagus nerve-preserving gastrectomy cohort, respectively. The model effectively differentiated between high- and low-risk groups in terms of postoperative survival. CONCLUSIONS: Vagus nerve-preserving gastrectomy can improve the patients' postoperative quality of life and ensure safety in the perioperative period. The vagus nerve-associated lymph node metastasis risk assessment model is a crucial tool in guiding the selection of optimal surgical procedures and treatment strategies for early gastric cancer patients.
引用
- Wang X, Wang X, You Q, et al. Risk assessment of lymph node metastasis in early gastric cancer patients with vagus nerve-preserving gastrectomy: A multiple centers potential analysis in China. Surgery. 2025. PMID: 40373505. doi:10.1016/j.surg.2025.109411
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。